My watch list
my.bionity.com  
Login  

Benign Prostatic Hypertrophy

News Benign Prostatic Hypertrophy

  • AmVac AG Granted a European Patent for ProstaVac

    European patent EP 1272216B1 with the title "Vaccine consisting of lactobacilli for the treatment of inflammation of the prostate and benign prostatic hyperplasia" was granted by the European Patent Office on9.6.2010. AmVac AG holds a licence for the above patent. Granting of the patent is a major more

  • Protox announces positive Phase 2b BPH results

    Protox Therapeutics Inc. announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH). The study achieved its primary clinical endpoint of a statistically significa more

  • Protox completes enrollment of Phase 2b BPH trial

    Protox Therapeutics Inc. announced that it has completed patient enrollment in its multi-centre, double-blinded, placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in males with moderate to severe benign prostatic hyperplasia (BPH). TRIUMPH is the third BPH clinical trial of PRX302 c more

All news on benign prostatic hypertrophy

Publications Benign Prostatic Hypertrophy

All publications on benign prostatic hypertrophy

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE